Prostate cancer incidence is predicted to double to 2·9 million cases by 2040. Men diagnosed with clinically significant ...
Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as ...
The Article by Tamim Niazi and colleagues1 on the Prostate Cancer Study 9 (PCS-9) investigated stereotactic body radiotherapy ...
This is a preview. Log in through your library . Abstract Introduction The common tool for diagnosing prostate cancer is prostate-specific antigen (PSA), but the high sensitivity and low specificity ...
Performance and Operational Feasibility of Epstein-Barr Virus–Based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches Activation of the androgen ...
Background: The association of infection or inflammation of the prostate with prostate cancer has been suggested but not established. This study was undertaken to investigate this association. Methods ...
Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From Diagnosis to Novel Therapeutic Horizons Prostate cancer (PCa) is the second most commonly diagnosed cancer in men with around ...
A recurrence means that the prostate cancer has not been cured by the initial treatment. Surviving prostate cancer cells have become evident again on evaluation. Usually after surgery to remove the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback